Para su Difusión
FTC Puts Conditions on Akorn, Inc.’s Proposed Acquisition of VersaPharm Inc
Fecha
Pharmaceutical company Akorn, Inc. has agreed to sell its rights to develop, manufacture, and market the generic injectable tuberculosis drug, rifampin, in order to settle FTC charges that Akorn’s...